Skip to content

Latest

Bausch+Lomb to acquire Ista Pharmaceuticals

Bausch+Lomb has unveiled a $500 million deal to acquire Ista Pharmaceuticals Inc., a maker of branded prescription drugs for eye care. Bausch+Lomb said Monday that the transaction, which has been unanimously approved by the boards of both companies, is slated to close in the second quarter.

McKesson wraps up purchase of Katz units

McKesson Corp. has closed its acquisition of the independent banner and franchise pharmacy businesses of Katz Group Canada Inc. The pharmaceutical distributor said Monday that it finalized the transaction on March 25.

Walgreens sees earnings decrease in 2Q

Walgreens sees earnings decrease in 2Q

Walgreen Co. cited a weak cold and flu season and its impasse with pharmacy benefit manager Express Scripts Inc. in reporting declined earnings and prescription sales for its fiscal 2012 second quarter. Walgreens said Tuesday that for the second quarter ended Feb.

Rite Aid clarifies its wellness ambassador role

After two U.S. senators expressed concerns, Rite Aid Corp. has reiterated the role of its “wellness ambassador,” a key customer service feature of the drug chain’s new “wellness store” format. In press announcements this month, Sens. Richard Durbin (D., Ill.) and Richard Blumenthal (D., Conn.

Retail sales are on the upswing

Retail sales in February showed the highest gain in five months, and the industry’s largest drug chains mirrored the broader trend. At Rite Aid Corp., for instance, total sales for the five weeks ended March 3 increased 2.3% to $2.55 billion, up from $2.

CVS, Cardinal win round in DEA fight

Cardinal Health Inc. and CVS Caremark Corp. have won reprieves from the Drug Enforcement Administration’s (DEA’s) efforts to have them stop selling certain prescription drugs in Florida. In separate rulings a week apart, the U.S.

Chains have no tolerance for Rx diversion

Chain pharmacies have “zero tolerance” for prescription drug diversion, the National Association of Chain Drug Stores told a congressional subcommittee earlier this month. Testifying before the House Subcommittee on Commerce, Manufacturing and Trade, chaired by Rep. Mary Bono Mack (R., Calif.

A move toward greater transparency

The Utah state legislature’s passage of a bill that would require audits conducted by pharmacy benefit managers (PBMs) to be “fair and rational” has been praised by the National Association of Chain Drug Stores, which asserts that the action addresses the concern that PBMs jeopardize neighborhood ph